Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Gene expression profiling predicts clinical outcome of breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH.

Nature. 2002 Jan 31;415(6871):530-6.

PMID:
11823860
2.

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.

Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A.

Nature. 2001 Sep 6;413(6851):83-6.

PMID:
11544530
3.

Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.

Randle DH, Zindy F, Sherr CJ, Roussel MF.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9654-9. Epub 2001 Jul 31.

4.

Specific protection against breast cancers by cyclin D1 ablation.

Yu Q, Geng Y, Sicinski P.

Nature. 2001 Jun 28;411(6841):1017-21.

PMID:
11429595
5.

Escape from premature senescence is not sufficient for oncogenic transformation by Ras.

Peeper DS, Dannenberg JH, Douma S, te Riele H, Bernards R.

Nat Cell Biol. 2001 Feb;3(2):198-203.

PMID:
11175753
6.
7.

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M.

Nat Genet. 2000 Nov;26(3):291-9.

PMID:
11062467
8.

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM.

Immunity. 2000 Aug;13(2):199-212.

9.

Cellular senescence: mitotic clock or culture shock?

Sherr CJ, DePinho RA.

Cell. 2000 Aug 18;102(4):407-10. Review. No abstract available.

10.

Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: pathogenetic and histogenetic implications.

Ariatti C, Vivenza D, Capello D, Migliazza A, Parvis G, Fassone L, Buonaiuto D, Savinelli F, Rossi D, Saglio G, Gaidano G.

Hum Pathol. 2000 Jul;31(7):871-3.

PMID:
10923927
11.

A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts.

Berns K, Hijmans EM, Koh E, Daley GQ, Bernards R.

Oncogene. 2000 Jul 6;19(29):3330-4.

12.

p16 INK4a can initiate an autonomous senescence program.

Dai CY, Enders GH.

Oncogene. 2000 Mar 23;19(13):1613-22.

13.

The molecular and cellular origins of Hodgkin's disease.

Staudt LM.

J Exp Med. 2000 Jan 17;191(2):207-12. Review. No abstract available.

14.
15.

Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells.

Heemskerk MH, Hooijberg E, Ruizendaal JJ, van der Weide MM, Kueter E, Bakker AQ, Schumacher TN, Spits H.

Cell Immunol. 1999 Jul 10;195(1):10-7.

PMID:
10433792
16.

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus.

Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M.

Nature. 1999 Jan 14;397(6715):164-8.

PMID:
9923679
17.

p14ARF links the tumour suppressors RB and p53.

Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH.

Nature. 1998 Sep 10;395(6698):124-5. No abstract available.

PMID:
9744267
18.

Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo.

Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH, Conti CJ.

Genes Dev. 1998 Aug 15;12(16):2469-74.

19.

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF.

Genes Dev. 1998 Aug 1;12(15):2424-33.

20.

Expression of the BCL6 gene in the pre- and postnatal mouse.

Bajalica-Lagercrantz S, Piehl F, Farnebo F, Larsson C, Lagercrantz J.

Biochem Biophys Res Commun. 1998 Jun 18;247(2):357-60.

PMID:
9642131
Items per page

Supplemental Content

Write to the Help Desk